Home > Products > CD3 & CD74
> Recombinant Anti-CD3 x Anti-CD74 VHH BispecificAntibody (IgG-VHH)
Recombinant Anti-CD3 x Anti-CD74 VHH BispecificAntibody (IgG-VHH) (CAT#: IGVHH-015)
Recombinant Anti-CD3 x Anti-CD74 Bispecific Antibody (IgG-VHH) is designed to be expressed as a LC and an extended HC with VHH moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Multiple myeloma (MM) therapy.
CD74; Cluster of differentiation 74; CD74 molecule; CD74 antigen; CD74 molecule, major histocompatibility complex, class II invariant chain; II; DHLAG; HLADG; Ia-GAMMA; HLA class II histocompatibility antigen gamma chain; p33; HLA-DR-gamma; MHC HLA-DR gamma chain; Ia-associated invariant chain; gamma chain of class II antigens; HLA-DR antigens-associated invariant chain; CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CD74 VHH BispecificAntibody (IgG-VHH) (IGVHH-015). Click the button below to contact us or submit your feedback about this product.